ARMONAIR RESPICLICK Drug Patent Profile
✉ Email this page to a colleague
When do Armonair Respiclick patents expire, and when can generic versions of Armonair Respiclick launch?
Armonair Respiclick is a drug marketed by Teva Pharm and is included in one NDA. There are thirteen patents protecting this drug.
This drug has three hundred and three patent family members in thirty-two countries.
The generic ingredient in ARMONAIR RESPICLICK is fluticasone propionate. There are twenty-nine drug master file entries for this compound. Seventy-two suppliers are listed for this compound. Additional details are available on the fluticasone propionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Armonair Respiclick
A generic version of ARMONAIR RESPICLICK was approved as fluticasone propionate by FOUGERA PHARMS on May 14th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ARMONAIR RESPICLICK?
- What are the global sales for ARMONAIR RESPICLICK?
- What is Average Wholesale Price for ARMONAIR RESPICLICK?
Summary for ARMONAIR RESPICLICK
International Patents: | 303 |
US Patents: | 13 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 86 |
Patent Applications: | 5,456 |
Drug Prices: | Drug price information for ARMONAIR RESPICLICK |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ARMONAIR RESPICLICK |
DailyMed Link: | ARMONAIR RESPICLICK at DailyMed |
Pharmacology for ARMONAIR RESPICLICK
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for ARMONAIR RESPICLICK
ARMONAIR RESPICLICK is protected by thirteen US patents and three FDA Regulatory Exclusivities.
Expired US Patents for ARMONAIR RESPICLICK
International Patents for ARMONAIR RESPICLICK
See the table below for patents covering ARMONAIR RESPICLICK around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 2007289716 | MEDICAMENT INHALER | ⤷ Subscribe |
Eurasian Patent Organization | 201991706 | ИНГАЛЯТОРЫ И АДАПТЕРЫ ВОЗДУШНОГО ПОТОКА ДЛЯ ИНГАЛЯТОРОВ | ⤷ Subscribe |
Denmark | 1667627 | ⤷ Subscribe | |
Spain | 2544278 | ⤷ Subscribe | |
Spain | 2529229 | ⤷ Subscribe | |
European Patent Office | 2514462 | ⤷ Subscribe | |
Taiwan | I224511 | ⤷ Subscribe | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ARMONAIR RESPICLICK
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2506844 | 2018C/022 | Belgium | ⤷ Subscribe | PRODUCT NAME: EEN FARMACEUTISCH COMBINATIEPRODUCT DAT EEN FARMACEUTISCH AANVAARDBAAR ZOUT VAN UMECLIDINIUM (BV. UMECLIDINIUMBROMIDE), VILANTEROL OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN (BV. VILANTEROLTRIFENATAAT) EN FLUTICASONEFUROAAT OMVAT; AUTHORISATION NUMBER AND DATE: EU/1/17/1236 20171117 |
1305329 | SPC/GB08/026 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: FLUTICASONE FUROATE AND SOLVATES THEREOF; REGISTERED: UK EU/1/07/434/001 20080116; UK EU/1/07/434/002 20080116; UK EU/1/07/434/003 20080116 |
1519731 | 132013902182575 | Italy | ⤷ Subscribe | PRODUCT NAME: AZELASTINA CLORIDRATO/FLUTICASONE PROPIONATO(DYMISTA); AUTHORISATION NUMBER(S) AND DATE(S): 2011/07125-REG, 20111024;041808015/M-027/M-039/M-041/M, 20130527 |
1519731 | 13C0067 | France | ⤷ Subscribe | PRODUCT NAME: AZELASTINE OU SES SELS PHARMACEUTIQUEMENT ACCEPTABLES ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE; NAT. REGISTRATION NO/DATE: NL41755 20130925; FIRST REGISTRATION: SK - 24/0055/13-S 20130215 |
1305329 | 08C0014 | France | ⤷ Subscribe | PRODUCT NAME: FLUTICASONE FUROATE; REGISTRATION NO/DATE: EU/1/07/434/001 20080111 |
1519731 | 92269 | Luxembourg | ⤷ Subscribe | PRODUCT NAME: AZELASTINE,OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUICI,ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE |
2506844 | LUC00077 | Luxembourg | ⤷ Subscribe | PRODUCT NAME: PRODUIT DE COMBINAISON PHARMACEUTIQUE COMPRENANT UN SEL PHARMACEUTIQUEMENT ACCEPTABLE D'UMECLIDINIUM (PAR EXEMPLE LE BROMURE D'UMECLIDINIUM), LE VILANTEROL OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLE (PAR EXEMPLE LE TRIFENATATE DE VILANTEROL) ET LE FUROATE DE FLUTICASONE; AUTHORISATION NUMBER AND DATE: EU/1/17/1236 20171117 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
ARMONAIR RESPICLICK Market Analysis and Financial Projection Experimental
More… ↓